Euthanasia.

von Illidge, T. M., Kirkham, S. R.
Veröffentlicht 1992

The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade

von Dovedi, S J, Illidge, T M
Veröffentlicht in Oncoimmunology (2015)

The influence of radiation in the context of developing combination immunotherapies in cancer

von Honeychurch, Jamie, Illidge, Timothy M.
Veröffentlicht in Ther Adv Vaccines Immunother (2018)

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity

von Honeychurch, Jamie, Dive, Caroline, Illidge, Timothy M.
Veröffentlicht 2013

Radiotherapy–Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?

von Romano, Erminia, Honeychurch, Jamie, Illidge, Timothy M.
Veröffentlicht in Cancers (Basel) (2021)

Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?

von Walshaw, Richard C, Honeychurch, Jamie, Illidge, Tim M
Veröffentlicht in Br J Radiol (2016)

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

von Colton, Madyson, Cheadle, Eleanor J., Honeychurch, Jamie, Illidge, Tim M.
Veröffentlicht in Radiat Oncol (2020)

Radiotherapy physics research in the UK: challenges and proposed solutions

von Mackay, R I, Burnet, N G, Green, S, Illidge, T M, Staffurth, J N
Veröffentlicht 2012

Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastrophe

von Kalejs, Martins, Ivanov, Andrey, Plakhins, Gregory, Cragg, Mark S, Emzinsh, Dzintars, Illidge, Timothy M, Erenpreisa, Jekaterina
Veröffentlicht 2006

A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

von Cheadle, E J, Lipowska-Bhalla, G, Dovedi, S J, Fagnano, E, Klein, C, Honeychurch, J, Illidge, T M
Veröffentlicht in Leukemia (2017)

Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

von Cheadle, E J, Lipowska-Bhalla, G, Dovedi, S J, Fagnano, E, Klein, C, Honeychurch, J, Illidge, T M
Veröffentlicht in Leukemia (2017)

Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response

von Melis, M H M, Simpson, K L, Dovedi, S J, Welman, A, MacFarlane, M, Dive, C, Honeychurch, J, Illidge, T M
Veröffentlicht 2013

Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway

von Honeychurch, Jamie, Alduaij, Waleed, Azizyan, Mahsa, Cheadle, Eleanor J., Pelicano, Helene, Ivanov, Andrei, Huang, Peng, Cragg, Mark S., Illidge, Tim M.
Veröffentlicht in Blood (2012)

Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CDS(+) T cells

von Dovedi, Simon J., Lipowska-Bhalla, Grazyna, Beers, Stephen A., Cheadle, Eleanor J., Mu, Lijun, Glennie, Martin J., Illidge, Timothy M., Honeychurch, Jamie
Veröffentlicht in Cancer Immunol Res (2016)

Akt inhibition improves long‐term tumour control following radiotherapy by altering the microenvironment

von Searle, Emma J, Telfer, Brian A, Mukherjee, Debayan, Forster, Duncan M, Davies, Barry R, Williams, Kaye J, Stratford, Ian J, Illidge, Tim M
Veröffentlicht in EMBO Mol Med (2017)

Endopolyploidy in irradiated p53-deficient tumour cell lines: Persistence of cell division activity in giant cells expressing Aurora B- kinase

von Erenpreisa, Jekaterina, Ivanov, Andrei, Wheatley, Sally P, Kosmacek, Elizabeth A, Ianzini, Fiorenza, Anisimov, Alim P, Mackey, Michael, Davis, Paul J, Plakhins, Grigorijs, Illidge, Timothy M
Veröffentlicht 2008

Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma

von Greystoke, A, O'Connor, J P B, Linton, K, Taylor, M B, Cummings, J, Ward, T, Maders, F, Hughes, A, Ranson, M, Illidge, T M, Radford, J, Dive, C
Veröffentlicht 2011

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

von Alduaij, Waleed, Ivanov, Andrei, Honeychurch, Jamie, Cheadle, Eleanor J., Potluri, Sandeep, Lim, Sean H., Shimada, Kazuyuki, Chan, Claude H. T., Tutt, Alison, Beers, Stephen A., Glennie, Martin J., Cragg, Mark S., Illidge, Tim M.
Veröffentlicht 2011

A novel systemically administered toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models

von Adlard, Amy L, Dovedi, Simon J, Telfer, Brian A, Koga-Yamakawa, Erina, Pollard, Charlotte, Honeychurch, Jamie, Illidge, Timothy M, Murata, Masashi, Robinson, David T, Jewsbury, Philip J, Wilkinson, Robert W, Stratford, Ian J
Veröffentlicht in Int J Cancer (2014)

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

von Illidge, Tim M., Phillips, Elizabeth H., Counsell, Nicholas, Pettengell, Ruth, Johnson, Peter W. M., Culligan, Dominic J., Popova, Bilyana, Clifton-Hadley, Laura, McMillan, Andrew, Hoskin, Peter, Barrington, Sally F., Radford, John
Veröffentlicht in Blood Adv (2020)